CVS Group

Updating our forecasts and revisiting the investment case

  • Sectors : Pharma and healthcare
  • Companies : CVS Group

Ratings and price correct at time of issue.

  • CVS Group

    Closing Price: 1058p

  • RATING 09/03/21

  • PREVIOUS RATING N/A

DAVY VIEW

We lower our EPS forecasts by 5-6% each year from higher depreciation and interest charges associated with investments. There are further risks to forecasts looking ahead. However, the stock is over 60% below its peak and is well below fair value. We expect relief from the conclusion of the Competition and Markets Authority (CMA) review later this year.

Download full report with analyst certification and important disclosures

Mar 19 2025, 07:00 GMT

Download